Skip to main content
CVSA
NYSE Trade & Services

Covista Reports Strong Revenue and Adjusted Earnings Growth, Proactive Debt Refinancing, and Continued Share Buybacks

Analysis by Arik Shkolnikov
Sentiment info
Positive
Importance info
8
Price
$119.51
Mkt Cap
$4.037B
52W Low
$86.97
52W High
$156.26
Market data snapshot near publication time

summarizeSummary

Covista Inc. reported strong revenue and adjusted earnings growth for Q3 and 9M fiscal 2026, driven by increased enrollment. The company also completed a favorable debt refinancing and continued its share repurchase program, despite a GAAP net income decline due to discontinued operations.


check_boxKey Events

  • Strong Revenue Growth

    Consolidated revenue increased 4.5% to $487.0 million in Q3 2026 and 9.1% to $1.45 billion for the nine months, driven by higher tuition rates and enrollment across all segments.

  • Adjusted Earnings Outperform GAAP

    Adjusted diluted EPS rose 3.1% to $1.98 in Q3 and 23.0% to $6.16 for the nine months, reflecting robust operational performance, despite a GAAP net income decline.

  • Strategic Debt Refinancing Completed

    On March 2, 2026, Covista incurred a new $510.0 million Term Loan B with a lower interest rate (SOFR + 2.25%) and extended maturity (March 2, 2033), while repaying previous Term Loan B and $405.0 million in Senior Secured Notes due 2028.

  • Active Share Repurchase Program

    The company repurchased $65.7 million of common stock in Q3 2026 and $238.2 million in the first nine months. A significant $661.8 million remains authorized under the current $750.0 million program.


auto_awesomeAnalysis

Covista Inc. delivered robust financial results for the third quarter and first nine months of fiscal year 2026, driven by strong enrollment growth across its educational segments. Revenue increased 4.5% in Q3 to $487.0 million and 9.1% for the nine months to $1.45 billion. Adjusted diluted EPS, a key non-GAAP metric, rose 3.1% to $1.98 in Q3 and a significant 23.0% to $6.16 for the nine-month period, indicating strong underlying operational performance. While GAAP net income and diluted EPS saw declines, this was primarily attributed to a $16.3 million loss from discontinued operations in Q3 2026, compared to a small income in the prior year. The company also proactively managed its capital structure by completing a debt refinancing on March 2, 2026, which included incurring a new $510.0 million Term Loan B with a later maturity (March 2, 2033) and a lower interest rate (SOFR + 2.25%), while fully repaying the previous Term Loan B and $405.0 million in Senior Secured Notes due 2028. Furthermore, Covista continued its share repurchase program, buying back $65.7 million in Q3 and $238.2 million in the first nine months, with a substantial $661.8 million remaining under authorization. The regulatory environment, including provisional Title IV certifications and new FVT/GE rules, remains a factor, but the company appears to be managing these known risks.

At the time of this filing, CVSA was trading at $119.51 on NYSE in the Trade & Services sector, with a market capitalization of approximately $4B. The 52-week trading range was $86.97 to $156.26. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed CVSA - Latest Insights

CVSA
May 07, 2026, 4:18 PM EDT
Filing Type: 10-Q
Importance Score:
8
CVSA
May 07, 2026, 4:13 PM EDT
Source: Wiseek News
Importance Score:
8
CVSA
Apr 09, 2026, 8:01 AM EDT
Filing Type: 8-K
Importance Score:
7